139 related articles for article (PubMed ID: 28314697)
1. Demeanor of rivaroxaban in activated/inactivated FXa.
Seki K; Mizuno Y; Sakashita T; Nakano S; Tanno J; Okazaki Y; Muramatsu T; Nishimura S; Senbonmatsu T
J Pharmacol Sci; 2017 Mar; 133(3):156-161. PubMed ID: 28314697
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values.
Siddiqui F; Tafur A; Ramacciotti LS; Jeske W; Hoppensteadt D; Ramacciotti E; Iqbal O; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619863493. PubMed ID: 31298056
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue.
Bukowska A; Zacharias I; Weinert S; Skopp K; Hartmann C; Huth C; Goette A
Eur J Pharmacol; 2013 Oct; 718(1-3):114-23. PubMed ID: 24041930
[TBL] [Abstract][Full Text] [Related]
4. Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran.
Ellinghaus P; Perzborn E; Hauenschild P; Gerdes C; Heitmeier S; Visser M; Summer H; Laux V
Thromb Res; 2016 Jun; 142():44-51. PubMed ID: 27131284
[TBL] [Abstract][Full Text] [Related]
5. Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium.
Álvarez E; Paradela-Dobarro B; Raposeiras-Roubín S; González-Juanatey JR
Br J Clin Pharmacol; 2018 Feb; 84(2):280-291. PubMed ID: 28940408
[TBL] [Abstract][Full Text] [Related]
6. A rapid pro-hemostatic approach to overcome direct oral anticoagulants.
Thalji NK; Ivanciu L; Davidson R; Gimotty PA; Krishnaswamy S; Camire RM
Nat Med; 2016 Aug; 22(8):924-32. PubMed ID: 27455511
[TBL] [Abstract][Full Text] [Related]
7. Activated Factor X Induces Endothelial Cell Senescence Through IGFBP-5.
Sanada F; Taniyama Y; Muratsu J; Otsu R; Iwabayashi M; Carracedo M; Rakugi H; Morishita R
Sci Rep; 2016 Oct; 6():35580. PubMed ID: 27752126
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Eur J Pharmacol; 2018 Feb; 820():222-228. PubMed ID: 29269019
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction.
Busch G; Seitz I; Steppich B; Hess S; Eckl R; Schömig A; Ott I
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):461-6. PubMed ID: 15550696
[TBL] [Abstract][Full Text] [Related]
10. An Inhibitor of Activated Blood Coagulation Factor X Shows Anti-Endothelial Senescence and Anti-Atherosclerotic Effects.
Maeda M; Tsuboi T; Hayashi T
J Vasc Res; 2019; 56(4):181-190. PubMed ID: 31266015
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T; Thienel M; Dannenberg L; Mourikis P; Helten C; Ayhan A; M'Pembele R; Achilles A; Trojovky K; Konsek D; Zhang Z; Regenauer R; Pircher J; Ehrlich A; Lüsebrink E; Nicolai L; Stocker TJ; Brandl R; Röschenthaler F; Strecker J; Saleh I; Spannagl M; Mayr CH; Schiller HB; Jung C; Gerdes N; Hoffmann T; Levkau B; Hohlfeld T; Zeus T; Schulz C; Kelm M; Polzin A
Circ Res; 2020 Feb; 126(4):486-500. PubMed ID: 31859592
[TBL] [Abstract][Full Text] [Related]
12. Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells.
Bukowska A; Schild L; Bornfleth P; Peter D; Wiese-Rischke C; Gardemann A; Isermann B; Walles T; Goette A
Eur J Pharmacol; 2020 Feb; 869():172875. PubMed ID: 31877279
[TBL] [Abstract][Full Text] [Related]
13. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells.
Lu Y; Zhu X; Liang GX; Cui RR; Liu Y; Wu SS; Liang QH; Liu GY; Jiang Y; Liao XB; Xie H; Zhou HD; Wu XP; Yuan LQ; Liao EY
Amino Acids; 2012 Nov; 43(5):2125-36. PubMed ID: 22532031
[TBL] [Abstract][Full Text] [Related]
14. Factor Xa and thrombin induce endothelial progenitor cell activation. The effect of direct oral anticoagulants.
Papadaki S; Sidiropoulou S; Moschonas IC; Tselepis AD
Platelets; 2021 Aug; 32(6):807-814. PubMed ID: 32762584
[TBL] [Abstract][Full Text] [Related]
15. Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.
Wang W; Yuan J; Fu X; Meng F; Zhang S; Xu W; Xu Y; Huang C
Molecules; 2016 Apr; 21(4):491. PubMed ID: 27089317
[TBL] [Abstract][Full Text] [Related]
16. Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
Steppich B; Dobler F; Brendel LC; Hessling G; Braun SL; Steinsiek AL; Deisenhofer I; Hyseni A; Roest M; Ott I
J Thromb Thrombolysis; 2017 May; 43(4):490-497. PubMed ID: 28316004
[TBL] [Abstract][Full Text] [Related]
17. Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts.
Bachli EB; Pech CM; Johnson KM; Johnson DJ; Tuddenham EG; McVey JH
J Thromb Haemost; 2003 Sep; 1(9):1935-44. PubMed ID: 12941034
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.
Ichikawa H; Shimada M; Narita M; Narita I; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H
J Am Heart Assoc; 2019 Apr; 8(8):e012195. PubMed ID: 30957622
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
20. Coagulation Factor Xa Induces Proinflammatory Responses in Cardiac Fibroblasts via Activation of Protease-Activated Receptor-1.
D'Alessandro E; Scaf B; Munts C; van Hunnik A; Trevelyan CJ; Verheule S; Spronk HMH; Turner NA; Ten Cate H; Schotten U; van Nieuwenhoven FA
Cells; 2021 Oct; 10(11):. PubMed ID: 34831181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
